🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Vaxcyte, Inc.

PCVX Healthcare
$55.39 $-2.97 (-5.09%)
Market Cap: $8.77 B
Gurus Holding
3
Popularity Rank
#2772
% of Shares Held
0.92%
Net Activity (Q3 2026)
-$15.11 M

Guru Ownership Trend

Guru Analysis for Vaxcyte, Inc. (PCVX)

Vaxcyte, Inc. (PCVX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $80.46 M.

Top institutional holders include Lee Ainslie and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $15.11 M net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 50.9%. Conversely, Ray Dalio reduced exposure by 19.6%.

Key Holders

Top 5 by Value

$77.39 M
$2.97 M
$2.3 M

Top 5 by Conviction

0.60%
0.01%
0.00%

Recent Activity Breakdown (Q3 2026)

+$1 M
Total Buy Value
New Buys 0
Additions 1
-$16.11 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for Vaxcyte, Inc. (PCVX)

Major holders include Lee Ainslie ($77.39 M), Cliff Asness ($2.97 M), Ray Dalio ($2.3 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.45 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $15.11 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited PCVX. The total reported sell value was $16.11 M.

Yes, 0 managers opened new positions in PCVX, and 1 increased their existing holdings. The total reported buy value was $1 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.60% Reduce -15.7% 1,360,031 $77.39 M Q3 2026
0.00% Add 50.9% 52,145 $2.97 M Q3 2026
0.01% Reduce -19.6% 40,377 $2.3 M Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form